1
|
Bellenger J, Bellenger S, Escoula Q, Bidu C, Narce M. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis. Biochimie 2019; 159:66-71. [PMID: 30690133 DOI: 10.1016/j.biochi.2019.01.017] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2018] [Accepted: 01/22/2019] [Indexed: 01/04/2023]
Abstract
Obesity is now widely recognized to be associated with low-grade systemic inflammation. It has been shown that high-fat feeding modulates gut microbiota which strongly increased intestinal permeability leading to lipopolysaccharide absorption causing metabolic endotoxemia that triggers inflammation and metabolic disorders. N-3 polyunsaturated fatty acids (PUFAs) have been shown associated with anti-obesity properties, but results still remain heterogeneous and very few studies underlined the metabolic pathways involved. Thus, the use of Fat-1 transgenic mice allows to better understanding whether endogenous n-3 PUFAs enrichment contributes to obesity and associated metabolic disorders prevention. It specially evidence that such effects occur through modulations of gut microbiota and intestinal permeability. Then, by remodeling gut microbiota, endogenous n-3 PUFAs improve HF/HS-diet induced features of the metabolic syndrome which in turn affects host metabolism. Thus, increasing anti-obesogenic microbial species in the gut microbiota population (i.e Akkermansia) by appropriate n-3 PUFAs may represent a promising strategy to control or prevent metabolic diseases.
Collapse
Affiliation(s)
- Jérôme Bellenger
- Université de Bourgogne Franche-Comté, UFR Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR UMR1231, 6 Boulevard Gabriel, 21000, Dijon, France; INSERM, Lipides Nutrition Cancer UMR1231, 21000, Dijon, France; LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, 21000, Dijon, France.
| | - Sandrine Bellenger
- Université de Bourgogne Franche-Comté, UFR Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR UMR1231, 6 Boulevard Gabriel, 21000, Dijon, France; INSERM, Lipides Nutrition Cancer UMR1231, 21000, Dijon, France; LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, 21000, Dijon, France
| | - Quentin Escoula
- Université de Bourgogne Franche-Comté, UFR Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR UMR1231, 6 Boulevard Gabriel, 21000, Dijon, France; INSERM, Lipides Nutrition Cancer UMR1231, 21000, Dijon, France; LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, 21000, Dijon, France; Valorex, La Messayais, 35210, Combourtillé, France
| | - Célia Bidu
- Université de Bourgogne Franche-Comté, UFR Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR UMR1231, 6 Boulevard Gabriel, 21000, Dijon, France; INSERM, Lipides Nutrition Cancer UMR1231, 21000, Dijon, France; LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, 21000, Dijon, France
| | - Michel Narce
- Université de Bourgogne Franche-Comté, UFR Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR UMR1231, 6 Boulevard Gabriel, 21000, Dijon, France; INSERM, Lipides Nutrition Cancer UMR1231, 21000, Dijon, France; LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, 21000, Dijon, France.
| |
Collapse
|
2
|
Bidu C, Escoula Q, Bellenger S, Spor A, Galan M, Geissler A, Bouchot A, Dardevet D, Morio-Liondor B, Cani PD, Lagrost L, Narce M, Bellenger J. Erratum. The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. Diabetes 2018;67:1512-1523. Diabetes 2019; 68:235. [PMID: 30455378 PMCID: PMC6302531 DOI: 10.2337/db19-er01a] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
3
|
Escoula Q, Bellenger S, Geissler A, Lagrost L, Narce M, Bellenger J. Les oméga-3 préviennent l’altération de la couche de mucus, le stress du réticulum endoplasmique et l’inflammation induits par un régime obésogène au niveau du colon de souris fat-1. NUTR CLIN METAB 2018. [DOI: 10.1016/j.nupar.2018.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
4
|
Bidu C, Escoula Q, Bellenger S, Spor A, Galan M, Geissler A, Bouchot A, Dardevet D, Morio B, Cani PD, Lagrost L, Narce M, Bellenger J. The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. Diabetes 2018; 67:1512-1523. [PMID: 29793999 DOI: 10.2337/db17-1488] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2017] [Accepted: 04/21/2018] [Indexed: 11/13/2022]
Abstract
Altering the gut microbiome may be beneficial to the host and recently arose as a promising strategy to manage obesity. Here, we investigated the relative contribution of ω3 polyunsaturated fatty acid (PUFA)-mediated alterations in the microbiota to metabolic parameter changes in mice. Four groups were compared: male fat-1 transgenic mice (with constitutive production of ω3 PUFAs) and male wild-type (WT) littermates fed an obesogenic (high fat/high sucrose [HFHS]) or a control diet. Unlike WT mice, HFHS-fed fat-1 mice were protected against obesity, glucose intolerance, and hepatic steatosis. Unlike WT mice, fat-1 mice maintained a normal barrier function, resulting in a significantly lower metabolic endotoxemia. The fat-1 mice displayed greater phylogenic diversity in the cecum, and fecal microbiota transplantation from fat-1 to WT mice was able to reverse weight gain and to normalize glucose tolerance and intestinal permeability. We concluded that the ω3 PUFA-mediated alteration of gut microbiota contributed to the prevention of metabolic syndrome in fat-1 mice. It occurred independently of changes in the PUFA content of host tissues and may represent a promising strategy to prevent metabolic disease and preserve a lean phenotype.
Collapse
Affiliation(s)
- Célia Bidu
- University of Bourgogne Franche-Comté, L'Unité de Formation Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR1231, Dijon, France
- INSERM, Lipides Nutrition Cancer UMR1231, Dijon, France
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, Dijon, France
| | - Quentin Escoula
- University of Bourgogne Franche-Comté, L'Unité de Formation Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR1231, Dijon, France
- INSERM, Lipides Nutrition Cancer UMR1231, Dijon, France
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, Dijon, France
| | - Sandrine Bellenger
- University of Bourgogne Franche-Comté, L'Unité de Formation Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR1231, Dijon, France
- INSERM, Lipides Nutrition Cancer UMR1231, Dijon, France
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, Dijon, France
| | - Aymé Spor
- Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1347, Agroécologie, Dijon, France
| | - Maxime Galan
- Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1062 Centre de Biologie pour la Gestion des Populations (Institut National de la Recherche Agronomique, L'Institut de Recherche pour le Développement, Centre de coopération Internationale en Recherche Agronomique pour le Développement, Montpellier SupAgro), Montferrier-sur-Lez, France
| | - Audrey Geissler
- CellImap-Cellular Imaging Platform, Faculté de Médecine et Pharmacie, Dijon, France
| | - André Bouchot
- CellImap-Cellular Imaging Platform, Faculté de Médecine et Pharmacie, Dijon, France
| | - Dominique Dardevet
- Clermont Université, Université d'Auvergne, Unité de Nutrition Humaine, Clermont-Ferrand, France
- Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1019, Unité de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand, France
| | - Béatrice Morio
- Institut National de la Recherche Agronomique , Unité Mixte de Recherche 1397, CarMeN Laboratory, Lyon 1 University, INSERM U1060, Institut National des Sciences Appliquées of Lyon, Rockefeller and Charles Merieux Lyon-Sud Medical Universities, Lyon, France
| | - Patrice D Cani
- Université Catholique de Louvain, Welbio (Walloon Excellence in Life Sciences and BIOtechnology), Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium
| | - Laurent Lagrost
- INSERM, Lipides Nutrition Cancer UMR1231, Dijon, France
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, Dijon, France
- L'Unité de Formation Médecine, Université de Bourgogne, Dijon, France
| | - Michel Narce
- University of Bourgogne Franche-Comté, L'Unité de Formation Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR1231, Dijon, France
- INSERM, Lipides Nutrition Cancer UMR1231, Dijon, France
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, Dijon, France
| | - Jérôme Bellenger
- University of Bourgogne Franche-Comté, L'Unité de Formation Sciences de la Vie, de la Terre et de l'Environnement, Lipides Nutrition Cancer UMR1231, Dijon, France
- INSERM, Lipides Nutrition Cancer UMR1231, Dijon, France
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, Dijon, France
| |
Collapse
|
5
|
Blasco-Baque V, Garidou L, Pomié C, Escoula Q, Loubieres P, Le Gall-David S, Lemaitre M, Nicolas S, Klopp P, Waget A, Azalbert V, Colom A, Bonnaure-Mallet M, Kemoun P, Serino M, Burcelin R. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut 2017; 66:872-885. [PMID: 26838600 PMCID: PMC5531227 DOI: 10.1136/gutjnl-2015-309897] [Citation(s) in RCA: 181] [Impact Index Per Article: 25.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/04/2015] [Accepted: 12/18/2015] [Indexed: 01/11/2023]
Abstract
OBJECTIVE To identify a causal mechanism responsible for the enhancement of insulin resistance and hyperglycaemia following periodontitis in mice fed a fat-enriched diet. DESIGN We set-up a unique animal model of periodontitis in C57Bl/6 female mice by infecting the periodontal tissue with specific and alive pathogens like Porphyromonas gingivalis (Pg), Fusobacterium nucleatum and Prevotella intermedia. The mice were then fed with a diabetogenic/non-obesogenic fat-enriched diet for up to 3 months. Alveolar bone loss, periodontal microbiota dysbiosis and features of glucose metabolism were quantified. Eventually, adoptive transfer of cervical (regional) and systemic immune cells was performed to demonstrate the causal role of the cervical immune system. RESULTS Periodontitis induced a periodontal microbiota dysbiosis without mainly affecting gut microbiota. The disease concomitantly impacted on the regional and systemic immune response impairing glucose metabolism. The transfer of cervical lymph-node cells from infected mice to naive recipients guarded against periodontitis-aggravated metabolic disease. A treatment with inactivated Pg prior to the periodontal infection induced specific antibodies against Pg and protected the mouse from periodontitis-induced dysmetabolism. Finally, a 1-month subcutaneous chronic infusion of low rates of lipopolysaccharides from Pg mimicked the impact of periodontitis on immune and metabolic parameters. CONCLUSIONS We identified that insulin resistance in the high-fat fed mouse is enhanced by pathogen-induced periodontitis. This is caused by an adaptive immune response specifically directed against pathogens and associated with a periodontal dysbiosis.
Collapse
Affiliation(s)
- Vincent Blasco-Baque
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France,Faculté de Chirurgie-Dentaire de Toulouse, Technical platform of Research in Odontology, Toulouse Cedex 09, France
| | - Lucile Garidou
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - Céline Pomié
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - Quentin Escoula
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - Pascale Loubieres
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France,Faculté de Chirurgie-Dentaire de Toulouse, Technical platform of Research in Odontology, Toulouse Cedex 09, France
| | | | - Mathieu Lemaitre
- Faculté de Chirurgie-Dentaire de Toulouse, Technical platform of Research in Odontology, Toulouse Cedex 09, France
| | - Simon Nicolas
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - Pascale Klopp
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - Aurélie Waget
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - Vincent Azalbert
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - André Colom
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | | | - Philippe Kemoun
- Faculté de Chirurgie-Dentaire de Toulouse, Technical platform of Research in Odontology, Toulouse Cedex 09, France
| | - Matteo Serino
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| | - Rémy Burcelin
- INSERM U1048, Toulouse, France,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France,Université Paul Sabatier (UPS), Toulouse, France
| |
Collapse
|